Free Trial

Alcon (ALC) Stock Forecast & Price Target

Alcon logo
$84.76 +0.58 (+0.69%)
(As of 12/20/2024 05:15 PM ET)

Alcon - Analysts' Recommendations and Stock Price Forecast (2025)

MarketBeat calculates consensus analyst ratings for stocks using the most recent rating from each Wall Street analyst that has rated a stock within the last twelve months. Each analyst's rating is normalized to a standardized rating score of 1 (sell), 2 (hold), 3 (buy) or 4 (strong buy). Analyst consensus ratings scores are calculated using the mean average of the number of normalized sell, hold, buy and strong buy ratings from Wall Street analysts. Each stock's consensus analyst rating is derived from its calculated consensus ratings score (0 to .5 = Strong Sell, .5 to 1 = Sell, 1 to 1.5 = Reduce, 1.5 to 2.5 = Hold, 2.5 to 3.0 = Moderate Buy, 3.0 to 3.5 = Buy, >3.5 = Strong Buy). MarketBeat's consensus price targets are a mean average of the most recent available price targets set by each analyst that has set a price target for the stock in the last twelve months. MarketBeat's consensus ratings and consensus price targets may differ from those calculated by other firms due to differences in methodology and available data.

Consensus Rating

Sell
0
Hold
3
Buy
11

Based on 14 Wall Street analysts who have issued ratings for Alcon in the last 12 months, the stock has a consensus rating of "Moderate Buy." Out of the 14 analysts, 3 have given a hold rating, and 11 have given a buy rating for ALC.

Consensus Price Target

$102.72
21.19% Upside
According to the 14 analysts' twelve-month price targets for Alcon, the average price target is $102.72. The highest price target for ALC is $110.00, while the lowest price target for ALC is $85.00. The average price target represents a forecasted upside of 21.19% from the current price of $84.76.
Get the Latest News and Ratings for ALC and Related Stocks

Enter your email address to receive the latest news and analysts' ratings for Alcon and its competitors.

Sign Up

ALC Analyst Ratings Over Time

TypeCurrent Forecast
12/23/23 to 12/22/24
1 Month Ago
11/23/23 to 11/22/24
3 Months Ago
9/24/23 to 9/23/24
1 Year Ago
12/23/22 to 12/23/23
Strong Buy
0 Strong Buy rating(s)
0 Strong Buy rating(s)
0 Strong Buy rating(s)
0 Strong Buy rating(s)
Buy
11 Buy rating(s)
12 Buy rating(s)
13 Buy rating(s)
9 Buy rating(s)
Hold
3 Hold rating(s)
2 Hold rating(s)
1 Hold rating(s)
1 Hold rating(s)
Sell
0 Sell rating(s)
0 Sell rating(s)
1 Sell rating(s)
2 Sell rating(s)
Consensus Price Target$102.72$102.63$99.74$88.53
Forecasted Upside21.19% Upside19.35% Upside1.81% Upside14.75% Upside
Consensus Rating
Moderate Buy
Moderate Buy
Moderate Buy
Moderate Buy

ALC Analyst Recommendations By Month

The chart below shows how a company's ratings by analysts have changed over time. Each bar represents the previous year of ratings for that month. Within each bar, the sell ratings are shown in red, the hold ratings are shown in yellow, the buy ratings are shown in green, and the strong buy ratings are shown in dark green.
Skip Chart & View Analyst Rating History

ALC Price Targets by Month

The chart below shows how a company's share price and consensus price target have changed over time. The dark blue line represents the company's actual price. The lighter blue line represents the stock's consensus price target. The even lighter blue range in the background of the two lines represents the low price target and the high price target for each stock.
Skip Chart and View Analyst Price Target HistorySkip Chart & View Price History Table

Alcon Stock vs. The Competition

TypeAlconMedical CompaniesS&P 500
Consensus Rating Score
2.79
2.81
2.51
Consensus RatingModerate BuyModerate BuyModerate Buy
Predicted Upside21.19% Upside25,827.32% Upside14.53% Upside
News Sentiment Rating
Neutral News

See Recent ALC News
Positive News
Positive News
DateBrokerageAnalyst NameActionRatingPrice TargetUpside/Downside on Report DateDetails
12/17/2024Needham & Company LLC
2 of 5 stars
 Reiterated RatingBuy ➝ Buy$103.00 ➝ $108.00+28.76%
11/26/2024BTIG Research
2 of 5 stars
R. Zimmerman
Subscribe to MarketBeat All Access for the recommendation accuracy rating
DowngradeStrong-Buy ➝ Hold
10/15/2024KeyCorp
3 of 5 stars
 Boost TargetOverweight ➝ Overweight$103.00 ➝ $107.00+10.08%
10/10/2024Redburn Atlantic
Subscribe to MarketBeat All Access for the recommendation accuracy rating
I. Kirby
Subscribe to MarketBeat All Access for the recommendation accuracy rating
UpgradeSell ➝ Neutral
9/10/2024Royal Bank of Canada
Subscribe to MarketBeat All Access for the recommendation accuracy rating
J. Reynolds-Clar
Subscribe to MarketBeat All Access for the recommendation accuracy rating
UpgradeSector Perform ➝ Outperform
8/22/2024Wells Fargo & Company
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 Boost TargetOverweight ➝ Overweight$94.00 ➝ $105.00+9.88%
Could This Tiny Device Help You Make an Extra $30k a Year? (Ad)

I believe it’s going to power Elon Musk’s next AI revolution… A revolution he believes will be worth more than $9 trillion. That’s nearly 10 times more money than the market caps of Tesla… SpaceX… PayPal… Neuralink… and X… COMBINED.

Click here to see the details because I believe a lot of people will get rich.
8/22/2024Oppenheimer
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 Boost TargetOutperform ➝ Outperform$103.00 ➝ $110.00+16.25%
8/22/2024Robert W. Baird
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 Boost TargetOutperform ➝ Outperform$104.00 ➝ $110.00+16.25%
7/15/2024Morgan Stanley
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 UpgradeUnderweight ➝ Equal Weight$65.00 ➝ $85.00-7.35%
5/15/2024Stifel Nicolaus
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 Reiterated RatingBuy ➝ Buy$95.00 ➝ $100.00+12.02%
5/15/2024Mizuho
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 Boost TargetBuy ➝ Buy$100.00 ➝ $105.00+17.62%
4/10/2024The Goldman Sachs Group
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 Initiated CoverageBuy$100.00+20.95%
3/4/2024Argus
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 Boost TargetBuy ➝ Buy$90.00 ➝ $100.00+16.31%
2/29/2024Sanford C. Bernstein
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 Boost TargetOutperform ➝ Outperform$93.00 ➝ $96.60+13.10%
11/20/2023Jefferies Financial Group
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 Lower TargetBuy ➝ Buy$94.00 ➝ $88.00+23.40%
8/17/2023JPMorgan Chase & Co.
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 UpgradeNeutral ➝ Overweight$79.80 ➝ $89.30+11.29%
3/1/2023Societe Generale
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 UpgradeSell ➝ Hold

Analyst ratings data on MarketBeat is provided by Benzinga and other data providers. This page was last refreshed on Sunday at 08:57 AM ET.


Should I Buy Alcon Stock? ALC Pros and Cons Explained

These pros and cons were generated based on recent news and financial data from MarketBeat in order to provide readers with the fastest and most accurate insights. They were last updated on Friday, December 13, 2024. Please send any questions or comments about these Alcon pros and cons to contact@marketbeat.com.

Alcon
Bull Case

green Wall Street bull icon

Here are some ways that investors could benefit from investing in Alcon Inc.:

  • Alcon Inc. has shown a strong fifty-two week performance of 26.72%, indicating a positive trend in its stock price over the past year, which can attract investors looking for growth.
  • The current stock price is $91.98, which reflects the company's market valuation and can be seen as a point of entry for potential investors.
  • With an average daily volume of 695,900 shares, there is significant trading activity, suggesting liquidity and ease of buying or selling shares.
  • Institutional ownership is at 72.64%, indicating that a large portion of the company is held by institutional investors, which can be a sign of confidence in the company's future prospects.
  • The short percentage of float is relatively low at 0.65%, suggesting that there is not a significant amount of bearish sentiment against the stock, which can be a positive indicator for potential investors.

Alcon
Bear Case

red Wall Street bear icon

Investors should be bearish about investing in Alcon Inc. for these reasons:

  • There has been a month-to-month decrease in shares shorted, from 3,430,000 to 3,160,000, which may indicate a lack of confidence in the stock's upward movement.
  • The institutional ownership percentage dropped to 0%, which could suggest a lack of confidence from institutional investors, potentially leading to volatility.
  • Despite a positive performance, the average daily volume has decreased from 810,500 to 695,900, indicating reduced trading interest, which could affect liquidity.
  • The days to cover has increased slightly to 4.5, which means it would take longer for short sellers to cover their positions, potentially indicating bearish sentiment.
  • The month-to-month change percentage in shares shorted is negative at -7.87%, which could reflect a trend of decreasing investor confidence in the stock's performance.

ALC Forecast - Frequently Asked Questions

According to the research reports of 14 Wall Street equities research analysts, the average twelve-month stock price forecast for Alcon is $102.72, with a high forecast of $110.00 and a low forecast of $85.00.

14 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Alcon in the last year. There are currently 3 hold ratings and 11 buy ratings for the stock. The consensus among Wall Street analysts is that investors should "moderate buy" ALC shares.

According to analysts, Alcon's stock has a predicted upside of 21.19% based on their 12-month stock forecasts.

Over the previous 90 days, Alcon's stock had 1 upgrade and 1 downgrade by analysts.

Alcon has been rated by research analysts at BTIG Research, KeyCorp, Needham & Company LLC, and Redburn Atlantic in the past 90 days.

Analysts like Alcon less than other "medical" companies. The consensus rating score for Alcon is 2.79 while the average consensus rating score for "medical" companies is 2.81. Learn more on how ALC compares to other companies.


This page (NYSE:ALC) was last updated on 12/22/2024 by MarketBeat.com Staff
From Our Partners